查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1590597

臉部脂肪移植市場：依供體部位、類型、治療類型和最終用途 - 2025-2030 年全球預測

Facial Fat Transfer Market by Donor Site (Abdomen, Flanks, Thigh), Type (Autologous, Microlipoinjection), Treatment Type, End Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年臉部脂肪移植市場價值為16.9億美元，預計到2024年將達到19億美元，複合年成長率為12.56%，預計到2030年將達到38.7億美元。

臉部脂肪移植，或脂肪移植，涉及從身體的一部分採集脂肪並將其注射到臉部區域以恢復體積並恢復外觀。由於其雙重優點，該技術變得越來越必要：從身體多餘脂肪區域進行抽脂，以及出於美容或重組目的而增加臉部體積。其應用範圍廣泛，包括美容改善、糾正與老齡化相關的體積損失以及由於醫療狀況或創傷而進行的面部重組手術。最終使用領域包括整容手術診所、醫院和皮膚科中心。市場成長的推動因素包括對微創美容手術的需求不斷增加、消費者對自然效果的認知和偏好不斷提高，以及採集和移植技術的進步有助於提高安全性和功效。隨著美容旅遊業的不斷發展和中階人口的不斷增加，他們的可支配收入可用於美容增強，機會比比皆是。為了抓住這些機會，相關人員可以專注於教育潛在客戶、擴大服務組合以包括輔助性治療，以及投資針對新興市場的行銷宣傳活動。然而，市場面臨著治療成本高、患者安全擔憂以及由於脂肪吸收率和醫生技術水準等因素導致結果參差不齊等挑戰。解決這些障礙需要強調從業者培訓和認證，倡導標準化技術，並推廣侵入性較小且一致的技術。需要探索創新領域，例如透過生物技術進步提高脂肪移植物的存活率、開發更複雜的採集工具以及利用數位技術進行個人化治療計劃。隨著對個人化和微創美容解決方案的需求不斷成長，臉部脂肪移植市場潛力巨大。透過解決當前的挑戰並利用前沿研究，公司可以在這個不斷發展的行業中獲得更大的市場佔有率。

主要市場統計
基準年[2023] 16.9億美元
預測年份 [2024] 19億美元
預測年份 [2030] 38.7億美元
複合年成長率（%） 12.56%

市場動態：快速發展的臉部脂肪移植市場的關鍵市場洞察

供需的動態交互作用正在改變臉部脂肪移植市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 身體美學日益重要
    • 提高臉部脂肪移植成功率
    • 老年人口增加，消費者健康意識增強
  • 市場限制因素
    • 治療費用高
  • 市場機會
    • 乙醯胺酚生產的持續技術進步與現代化
    • 活性化醫療保健領域的研發活動
  • 市場挑戰
    • 技術缺陷和不透明的法規限制了大規模採用

波特五力：駕馭臉部脂肪移植市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解臉部脂肪移植市場的外部影響

外部宏觀環境因素對臉部脂肪移植市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解臉部脂肪移植市場的競爭狀況

對臉部脂肪移植市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，以應對日益激烈的競爭。

FPNV定位矩陣臉部脂肪移植市場供應商的績效評估

FPNV定位矩陣是評估臉部脂肪移植市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了臉部脂肪移植市場的成功之路

臉部脂肪移植市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 身體美學日益重要
      • 提高臉部脂肪移植手術的成功率
      • 老年人口和消費者健康意識的增加
    • 抑制因素
      • 手續成本高
    • 機會
      • 乙醯胺酚生產的持續技術進步與現代化
      • 醫療保健領域的研發活動增加
    • 任務
      • 限制大規模採用的程序的缺陷和不確定的規定
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 臉部脂肪移植市場供體網站

  • 腹部
  • 方面
  • 大腿

第7章臉部脂肪移植市場：依類型

  • 自體移植
  • 微脂注射

第8章依治療類型分類的臉部脂肪移植市場

  • 真皮填充劑
  • 脂肪注射

第9章臉部脂肪移植市場：依最終用途

  • 診所及手術中心
  • 醫院

第10章 美洲臉部脂肪移植市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太臉部脂肪移植市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東、非洲臉部脂肪移植市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Allergan PLC by AbbVie Inc.
  • Anica Therapeutics Inc.
  • Bausch Health Companies Inc. by Valeant Pharmaceuticals
  • Bioplus Co. Ltd.
  • Bioxis Pharmaceuticals
  • Cytori Therapeutics, Inc.
  • Emory Healthcare
  • Integra Lifesciences
  • Merz Pharma GmbH & Co KGaA
  • Ranfac Corp
  • Revance Therapeutics, Inc.
  • Sanofi SA
  • SciVision Biotech Inc.
  • Sinclair Pharma
  • Stanford Health Care
  • Suneva Medical
Product Code: MRR-432CBFF6F455

The Facial Fat Transfer Market was valued at USD 1.69 billion in 2023, expected to reach USD 1.90 billion in 2024, and is projected to grow at a CAGR of 12.56%, to USD 3.87 billion by 2030.

Facial fat transfer, or fat grafting, involves harvesting fat from one part of the body and injecting it into facial areas to restore volume and rejuvenate appearance. This technique is increasingly necessary due to its dual benefits: liposuction from body areas with excess fat, and facial volume enhancement for aesthetic or reconstructive purposes. Applications span cosmetic improvements, age-related volume loss corrections, and facial reconstructive surgeries due to medical conditions or trauma. End-use sectors include cosmetic surgery clinics, hospitals, and dermatological centers. Market growth is propelled by rising demand for minimally invasive aesthetic procedures, increasing consumer awareness and preference for natural-looking results, and technological advancements in harvesting and grafting techniques, contributing to improved safety and efficacy. Opportunities abound in the growing beauty tourism industry and the expanding middle-class population with disposable income to spend on aesthetic enhancements. To seize these opportunities, stakeholders could focus on educating potential clients, expanding service portfolios to include adjunctive therapies, and investing in marketing campaigns targeting emerging economies. However, the market faces challenges such as high procedure costs, patient safety concerns, and the variability in results due to factors like fat absorption rates and practitioner skill levels. Navigating these obstacles involves emphasizing practitioner training and certification, advocating for standardized procedures, and advancing less invasive or more consistent methodologies. Innovation areas ripe for exploration include improving fat graft survival rates through biotechnological advancements, developing more refined harvesting tools, and utilizing digital technologies for personalized treatment plans. As demand for personalized, less invasive aesthetic solutions continues to grow, the facial fat transfer market presents significant potential. By addressing current challenges and leveraging cutting-edge research, businesses can capture larger market shares in this evolving industry.

KEY MARKET STATISTICS
Base Year [2023] USD 1.69 billion
Estimated Year [2024] USD 1.90 billion
Forecast Year [2030] USD 3.87 billion
CAGR (%) 12.56%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Facial Fat Transfer Market

The Facial Fat Transfer Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing importance for body aesthetics
    • Growing success rate of facial fat grafting procedures
    • Rising geriatric population and consumer awareness about health
  • Market Restraints
    • High cost of the procedure
  • Market Opportunities
    • Ongoing technological advancements and modernization in the production of paracetamol
    • Rising research and development activities in the healthcare sector
  • Market Challenges
    • Shortcomings of the procedure limiting mass adoption and uncertain regulations

Porter's Five Forces: A Strategic Tool for Navigating the Facial Fat Transfer Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Facial Fat Transfer Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Facial Fat Transfer Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Facial Fat Transfer Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Facial Fat Transfer Market

A detailed market share analysis in the Facial Fat Transfer Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Facial Fat Transfer Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Facial Fat Transfer Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Facial Fat Transfer Market

A strategic analysis of the Facial Fat Transfer Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Facial Fat Transfer Market, highlighting leading vendors and their innovative profiles. These include Allergan PLC by AbbVie Inc., Anica Therapeutics Inc., Bausch Health Companies Inc. by Valeant Pharmaceuticals, Bioplus Co. Ltd., Bioxis Pharmaceuticals, Cytori Therapeutics, Inc., Emory Healthcare, Integra Lifesciences, Merz Pharma GmbH & Co KGaA, Ranfac Corp, Revance Therapeutics, Inc., Sanofi S.A., SciVision Biotech Inc., Sinclair Pharma, Stanford Health Care, and Suneva Medical.

Market Segmentation & Coverage

This research report categorizes the Facial Fat Transfer Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Donor Site, market is studied across Abdomen, Flanks, and Thigh.
  • Based on Type, market is studied across Autologous and Microlipoinjection.
  • Based on Treatment Type, market is studied across Dermal Fillers and Fat Injections.
  • Based on End Use, market is studied across Clinics & Surgery Centers and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing importance for body aesthetics
      • 5.1.1.2. Growing success rate of facial fat grafting procedures
      • 5.1.1.3. Rising geriatric population and consumer awareness about health
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of the procedure
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing technological advancements and modernization in the production of paracetamol
      • 5.1.3.2. Rising research and development activities in the healthcare sector
    • 5.1.4. Challenges
      • 5.1.4.1. Shortcomings of the procedure limiting mass adoption and uncertain regulations
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Facial Fat Transfer Market, by Donor Site

  • 6.1. Introduction
  • 6.2. Abdomen
  • 6.3. Flanks
  • 6.4. Thigh

7. Facial Fat Transfer Market, by Type

  • 7.1. Introduction
  • 7.2. Autologous
  • 7.3. Microlipoinjection

8. Facial Fat Transfer Market, by Treatment Type

  • 8.1. Introduction
  • 8.2. Dermal Fillers
  • 8.3. Fat Injections

9. Facial Fat Transfer Market, by End Use

  • 9.1. Introduction
  • 9.2. Clinics & Surgery Centers
  • 9.3. Hospitals

10. Americas Facial Fat Transfer Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Facial Fat Transfer Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Facial Fat Transfer Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Allergan PLC by AbbVie Inc.
  • 2. Anica Therapeutics Inc.
  • 3. Bausch Health Companies Inc. by Valeant Pharmaceuticals
  • 4. Bioplus Co. Ltd.
  • 5. Bioxis Pharmaceuticals
  • 6. Cytori Therapeutics, Inc.
  • 7. Emory Healthcare
  • 8. Integra Lifesciences
  • 9. Merz Pharma GmbH & Co KGaA
  • 10. Ranfac Corp
  • 11. Revance Therapeutics, Inc.
  • 12. Sanofi S.A.
  • 13. SciVision Biotech Inc.
  • 14. Sinclair Pharma
  • 15. Stanford Health Care
  • 16. Suneva Medical

LIST OF FIGURES

  • FIGURE 1. FACIAL FAT TRANSFER MARKET RESEARCH PROCESS
  • FIGURE 2. FACIAL FAT TRANSFER MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FACIAL FAT TRANSFER MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FACIAL FAT TRANSFER MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL FACIAL FAT TRANSFER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS FACIAL FAT TRANSFER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS FACIAL FAT TRANSFER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES FACIAL FAT TRANSFER MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES FACIAL FAT TRANSFER MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC FACIAL FAT TRANSFER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC FACIAL FAT TRANSFER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA FACIAL FAT TRANSFER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA FACIAL FAT TRANSFER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. FACIAL FAT TRANSFER MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. FACIAL FAT TRANSFER MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FACIAL FAT TRANSFER MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FACIAL FAT TRANSFER MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL FACIAL FAT TRANSFER MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL FACIAL FAT TRANSFER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. FACIAL FAT TRANSFER MARKET DYNAMICS
  • TABLE 7. GLOBAL FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL FACIAL FAT TRANSFER MARKET SIZE, BY ABDOMEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL FACIAL FAT TRANSFER MARKET SIZE, BY FLANKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL FACIAL FAT TRANSFER MARKET SIZE, BY THIGH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL FACIAL FAT TRANSFER MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL FACIAL FAT TRANSFER MARKET SIZE, BY MICROLIPOINJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL FACIAL FAT TRANSFER MARKET SIZE, BY DERMAL FILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL FACIAL FAT TRANSFER MARKET SIZE, BY FAT INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL FACIAL FAT TRANSFER MARKET SIZE, BY CLINICS & SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL FACIAL FAT TRANSFER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS FACIAL FAT TRANSFER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES FACIAL FAT TRANSFER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC FACIAL FAT TRANSFER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA FACIAL FAT TRANSFER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM FACIAL FAT TRANSFER MARKET SIZE, BY DONOR SITE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM FACIAL FAT TRANSFER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM FACIAL FAT TRANSFER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM FACIAL FAT TRANSFER MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 188. FACIAL FAT TRANSFER MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 189. FACIAL FAT TRANSFER MARKET, FPNV POSITIONING MATRIX, 2023